Cargando…

Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort

AIMS/INTRODUCTION: Diabetic kidney disease (DKD) exacerbates dyslipidemia and increases the incidence of atherosclerotic cardiovascular disease. DKD is a concept that includes typical diabetic nephropathy and an atypical phenotype without proteinuria. We investigated dyslipidemia in different DKD ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Tsutomu, Satoh, Noriyuki, Kodera, Rieko, Hirashima, Takeshi, Suzuki, Natsuko, Aoki, Ema, Oshima, Taito, Hosoya, Mitsuru, Fujita, Masahiro, Hayashi, Toshiyuki, Ito, Yasuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017612/
https://www.ncbi.nlm.nih.gov/pubmed/34665936
http://dx.doi.org/10.1111/jdi.13697
_version_ 1784688813976584192
author Hirano, Tsutomu
Satoh, Noriyuki
Kodera, Rieko
Hirashima, Takeshi
Suzuki, Natsuko
Aoki, Ema
Oshima, Taito
Hosoya, Mitsuru
Fujita, Masahiro
Hayashi, Toshiyuki
Ito, Yasuki
author_facet Hirano, Tsutomu
Satoh, Noriyuki
Kodera, Rieko
Hirashima, Takeshi
Suzuki, Natsuko
Aoki, Ema
Oshima, Taito
Hosoya, Mitsuru
Fujita, Masahiro
Hayashi, Toshiyuki
Ito, Yasuki
author_sort Hirano, Tsutomu
collection PubMed
description AIMS/INTRODUCTION: Diabetic kidney disease (DKD) exacerbates dyslipidemia and increases the incidence of atherosclerotic cardiovascular disease. DKD is a concept that includes typical diabetic nephropathy and an atypical phenotype without proteinuria. We investigated dyslipidemia in different DKD phenotypes that have not been fully studied. MATERIALS AND METHODS: Fasting plasma was obtained from 1,073 diabetes patients enrolled in the regional diabetes cohort (ViNA cohort). Non‐proteinuric and proteinuric DKD were defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) in the absence or presence of urinary albumin‐to‐creatinine ratio >300 mg/g. Novel lipid risk factors, low‐density lipoprotein (LDL) triglyceride (TG) and small dense LDL cholesterol were measured using our established homologous assay. RESULTS: The proportion of atherosclerotic cardiovascular disease patients was higher in non‐proteinuric DKD and even higher in proteinuric DKD than in non‐DKD. Increased estimated glomerular filtration rate grade and albuminuric stage were independently correlated with higher TG, TG‐rich lipoprotein cholesterol and apolipoprotein CIII. Therefore, proteinuric DKD had the highest of these levels. Small dense LDL cholesterol and LDL‐TG were higher in the proteinuria without renal dysfunction group in the lipid‐lowering drug‐free subset. Lipoprotein(a) was higher in DKD regardless of proteinuria. CONCLUSIONS: Proteinuria was associated with an atherogenic subspecies of LDL, whereas renal dysfunction was associated with increased lipoprotein(a). Proteinuria and renal dysfunction independently exacerbated TG‐rich lipoprotein‐related dyslipidemia. This is in good agreement with the results of large‐scale clinical studies in which proteinuria and renal dysfunction synergistically increased the risk of atherosclerotic cardiovascular disease in populations with diabetes.
format Online
Article
Text
id pubmed-9017612
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90176122022-04-21 Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort Hirano, Tsutomu Satoh, Noriyuki Kodera, Rieko Hirashima, Takeshi Suzuki, Natsuko Aoki, Ema Oshima, Taito Hosoya, Mitsuru Fujita, Masahiro Hayashi, Toshiyuki Ito, Yasuki J Diabetes Investig Original Articles AIMS/INTRODUCTION: Diabetic kidney disease (DKD) exacerbates dyslipidemia and increases the incidence of atherosclerotic cardiovascular disease. DKD is a concept that includes typical diabetic nephropathy and an atypical phenotype without proteinuria. We investigated dyslipidemia in different DKD phenotypes that have not been fully studied. MATERIALS AND METHODS: Fasting plasma was obtained from 1,073 diabetes patients enrolled in the regional diabetes cohort (ViNA cohort). Non‐proteinuric and proteinuric DKD were defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2) in the absence or presence of urinary albumin‐to‐creatinine ratio >300 mg/g. Novel lipid risk factors, low‐density lipoprotein (LDL) triglyceride (TG) and small dense LDL cholesterol were measured using our established homologous assay. RESULTS: The proportion of atherosclerotic cardiovascular disease patients was higher in non‐proteinuric DKD and even higher in proteinuric DKD than in non‐DKD. Increased estimated glomerular filtration rate grade and albuminuric stage were independently correlated with higher TG, TG‐rich lipoprotein cholesterol and apolipoprotein CIII. Therefore, proteinuric DKD had the highest of these levels. Small dense LDL cholesterol and LDL‐TG were higher in the proteinuria without renal dysfunction group in the lipid‐lowering drug‐free subset. Lipoprotein(a) was higher in DKD regardless of proteinuria. CONCLUSIONS: Proteinuria was associated with an atherogenic subspecies of LDL, whereas renal dysfunction was associated with increased lipoprotein(a). Proteinuria and renal dysfunction independently exacerbated TG‐rich lipoprotein‐related dyslipidemia. This is in good agreement with the results of large‐scale clinical studies in which proteinuria and renal dysfunction synergistically increased the risk of atherosclerotic cardiovascular disease in populations with diabetes. John Wiley and Sons Inc. 2021-11-02 2022-04 /pmc/articles/PMC9017612/ /pubmed/34665936 http://dx.doi.org/10.1111/jdi.13697 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Hirano, Tsutomu
Satoh, Noriyuki
Kodera, Rieko
Hirashima, Takeshi
Suzuki, Natsuko
Aoki, Ema
Oshima, Taito
Hosoya, Mitsuru
Fujita, Masahiro
Hayashi, Toshiyuki
Ito, Yasuki
Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title_full Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title_fullStr Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title_full_unstemmed Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title_short Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross‐sectional study from a regional diabetes cohort
title_sort dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: a cross‐sectional study from a regional diabetes cohort
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017612/
https://www.ncbi.nlm.nih.gov/pubmed/34665936
http://dx.doi.org/10.1111/jdi.13697
work_keys_str_mv AT hiranotsutomu dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT satohnoriyuki dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT koderarieko dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT hirashimatakeshi dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT suzukinatsuko dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT aokiema dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT oshimataito dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT hosoyamitsuru dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT fujitamasahiro dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT hayashitoshiyuki dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort
AT itoyasuki dyslipidemiaindiabetickidneydiseaseclassifiedbyproteinuriaandrenaldysfunctionacrosssectionalstudyfromaregionaldiabetescohort